B

BaseLaunch

Europe, Basel-Landschaft, Switzerland, Allschwil

Description

The BaseLaunch accelerator is tailored to the needs of healthcare startups.

Investor Profile

BaseLaunch has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 80% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant, Pre Seed, Seed rounds (top funding stages).
  • Majority of deals are located in Switzerland, Spain.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Grant (50%)
  • Pre Seed (30%)
  • Seed (20%)

Country Focus

  • Switzerland (80%)
  • Spain (10%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Health Care
  • Life Science
  • Medical Device
  • Biopharma
  • Clinical Trials
  • Communities
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BaseLaunch frequently co-invest with?

Co-Investments: 1
Venture Kick
Europe, Zurich, Switzerland, Schlieren
Co-Investments: 1
K
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1

What are some of recent deals done by BaseLaunch?

Umlaut.Bio

Heidelberg, Baden-Wurttemberg, Germany

Umlaut.Bio is a spinout of the EMBL, is pursuing tRNA targets for treatment of cancer and immunological diseases.

Pre SeedFeb 20, 2026
Amount Raised: $3,536,693
NXI Therapeutics

Basel, Basel-Stadt, Switzerland

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

BiotechnologyLife ScienceMedicalTherapeutics
Pre SeedJun 18, 2024
Amount Raised: $3,935,410

Salvina Therapeutics is developing novel antibodies targeting TNF to overcome efficacy barriers in inflammatory and autoimmune diseases.

BiopharmaBiotechnologyLife Science
GrantOct 6, 2023
Amount Raised: $549,451
FimmCyte

Basel, Basel-Stadt, Switzerland

FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.

BiotechnologyMedical
GrantOct 6, 2023
Amount Raised: $549,451
Phialogics

Allschwil, Basel-Landschaft, Switzerland

Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.

BiotechnologyClinical Trials
GrantOct 6, 2023
Amount Raised: $549,451
Onena Medicines

Donostia-san Sebastián, Pais Vasco, Spain

Onena Medicines is a biotechnology company provides medical devices, antibodies to treat cancer and rare diseases.

BiotechnologyHealth CareMedical Device
GrantOct 6, 2023
Amount Raised: $549,451
Engimmune Therapeutics

Basel, Basel-Stadt, Switzerland

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

BiotechnologyTherapeutics
Pre SeedFeb 21, 2022
Amount Raised: $545,902
Aukera Therapeutics

Basel, Basel-Stadt, Switzerland

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.

BiotechnologyHealth CareTherapeutics
Pre SeedFeb 15, 2022
Amount Raised: $540,246
Stromal Therapeutics

Basel, Basel-Stadt, Switzerland

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

BiotechnologyTherapeutics
SeedJan 28, 2022
Amount Raised: $536,906
PharmaBiome

Zürich, Zurich, Switzerland

PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes.

BiotechnologyHealth CareMedical
SeedJan 21, 2020

Find More Investors Like BaseLaunch

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

BaseLaunch | Pipeseed